Consistent with this, induced systemic Pten overexpression in the mouse triggers a tumor suppressive and cancer protective state through healthy metabolism, which indicates that pharmacologic strategies able to increase levels or expression or activity of wild-type PTEN should be exploited as novel treatment modalities for cancer prevention and therapy [26]. The gene discussed is PTEN; the disease is cancer.